Report #2829813

Received Mar 5, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: OH
Recovered: Unknown
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HEP	HEP B (HEPLISAV-B)	DYNAVAX TECHNOLOGIES CORPORATION	UNK	—	—

Symptoms (1)

Exposure during pregnancy

Symptom narrative

Pregnant and Received Heplisav-B; Initial report received on 12-Feb-2025. A pharmacist reported that a female (race and ethnicity not reported) received HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization while pregnant. No medical history or concomitant medications were reported. On an unknown date, the patient received a dose of a hepatitis B vaccine [HEPLISAV-B (lot #, expiration date, NDC #, route and site not available)]. The patient was pregnant. No additional information was reported. Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.